Adverse events of inactivated COVID-19 vaccine in HIV-infected adults

Abstract This study aims to evaluate the safety of inactivated COVID-19 vaccine among adult people living with HIV (PLWH). In total, 259 PLWH who received at least one dose of inactivated COVID-19 vaccine were enrolled, and post-vaccination adverse events (AEs) were evaluated seven days following ea...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Songjie Wu, Yubin Zhang, Fangzhao Ming, Shi Zou, Mengmeng Wu, Wei Guo, Weiming Tang, Ke Liang
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	People living with HIV(PLWH) COVID-19 Inactivated vaccine Adverse event Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/27a2c038879e40c9841cbdbd7bcf23c9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:27a2c038879e40c9841cbdbd7bcf23c9
record_format	dspace
spelling	oai:doaj.org-article:27a2c038879e40c9841cbdbd7bcf23c92021-12-05T12:05:51ZAdverse events of inactivated COVID-19 vaccine in HIV-infected adults10.1186/s12981-021-00416-11742-6405https://doaj.org/article/27a2c038879e40c9841cbdbd7bcf23c92021-12-01T00:00:00Zhttps://doi.org/10.1186/s12981-021-00416-1https://doaj.org/toc/1742-6405Abstract This study aims to evaluate the safety of inactivated COVID-19 vaccine among adult people living with HIV (PLWH). In total, 259 PLWH who received at least one dose of inactivated COVID-19 vaccine were enrolled, and post-vaccination adverse events (AEs) were evaluated seven days following each vaccination dose. The overall AE frequency was 22.8% after dose one, which was higher than after dose two (10.2%) (P < 0.001). No severe side event or vaccine safety concern was observed. Our finding was essential in reducing vaccine hesitancy among PLWH.Songjie WuYubin ZhangFangzhao MingShi ZouMengmeng WuWei GuoWeiming TangKe LiangBMCarticlePeople living with HIV(PLWH)COVID-19Inactivated vaccineAdverse eventImmunologic diseases. AllergyRC581-607ENAIDS Research and Therapy, Vol 18, Iss 1, Pp 1-4 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	People living with HIV(PLWH) COVID-19 Inactivated vaccine Adverse event Immunologic diseases. Allergy RC581-607
spellingShingle	People living with HIV(PLWH) COVID-19 Inactivated vaccine Adverse event Immunologic diseases. Allergy RC581-607 Songjie Wu Yubin Zhang Fangzhao Ming Shi Zou Mengmeng Wu Wei Guo Weiming Tang Ke Liang Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
description	Abstract This study aims to evaluate the safety of inactivated COVID-19 vaccine among adult people living with HIV (PLWH). In total, 259 PLWH who received at least one dose of inactivated COVID-19 vaccine were enrolled, and post-vaccination adverse events (AEs) were evaluated seven days following each vaccination dose. The overall AE frequency was 22.8% after dose one, which was higher than after dose two (10.2%) (P < 0.001). No severe side event or vaccine safety concern was observed. Our finding was essential in reducing vaccine hesitancy among PLWH.
format	article
author	Songjie Wu Yubin Zhang Fangzhao Ming Shi Zou Mengmeng Wu Wei Guo Weiming Tang Ke Liang
author_facet	Songjie Wu Yubin Zhang Fangzhao Ming Shi Zou Mengmeng Wu Wei Guo Weiming Tang Ke Liang
author_sort	Songjie Wu
title	Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
title_short	Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
title_full	Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
title_fullStr	Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
title_full_unstemmed	Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
title_sort	adverse events of inactivated covid-19 vaccine in hiv-infected adults
publisher	BMC
publishDate	2021
url	https://doaj.org/article/27a2c038879e40c9841cbdbd7bcf23c9
work_keys_str_mv	AT songjiewu adverseeventsofinactivatedcovid19vaccineinhivinfectedadults AT yubinzhang adverseeventsofinactivatedcovid19vaccineinhivinfectedadults AT fangzhaoming adverseeventsofinactivatedcovid19vaccineinhivinfectedadults AT shizou adverseeventsofinactivatedcovid19vaccineinhivinfectedadults AT mengmengwu adverseeventsofinactivatedcovid19vaccineinhivinfectedadults AT weiguo adverseeventsofinactivatedcovid19vaccineinhivinfectedadults AT weimingtang adverseeventsofinactivatedcovid19vaccineinhivinfectedadults AT keliang adverseeventsofinactivatedcovid19vaccineinhivinfectedadults
_version_	1718372242748866560

Adverse events of inactivated COVID-19 vaccine in HIV-infected adults

Ejemplares similares